Sponsor Pipeline

Hemab ApS Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-23 NCT07347249
A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII Deficiency
date change Primary completion pushed: 2026-07 -> 2027-11
2026-07-23 NCT07347249
A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII Deficiency
date change Completion pushed: 2026-07 -> 2027-11
Active Trials by Phase
Phase 2
1
Phase 1/2
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07347249 A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII Deficiency Congenital Factor VII Deficiency Recruiting
Phase 1/2
NCT06754852 A Study Assessing HMB-002 in Participants With Von Willebrand Disease Von Willebrand Disease (VWD) Recruiting
NCT06211634 A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics… Glanzmann Thrombasthenia Active, Not Recruiting
Not specified
NCT06610201 A Study of Bleeding and Treatment in Participants With Von Willebrand Disease Von Willebrand Disease (VWD) Recruiting
Get alerts when Hemab ApS's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free